New Horizons in HIV Prevention Education: A Closer Look at Novel Therapies


Dan Scales, PharmD, AAHIVP
Director of Pharmacy Collaborative Care, Vivent Health, Denver, CO
Dan Scales, PharmD, AAHIVP

Dan Scales currently works as the Director of Pharmacy Collaborative Care at Vivent Health, overseeing clinical pharmacy and experiential education. Prior to merging with Vivent he owned and operated Scales Pharmacy, an HIV focused and sex-positive independent pharmacy in Denver, CO. Through his time at his own independent pharmacy and continuing as a part of Vivent Health, Dan Scales has pursued legislative and operational reform of pharmacy practice aiming to reduce disparities in health care by increasing access to pharmacy services. He is specifically interested in LGBTQIA rights and a harm reduction approach to health care, advocating for increased syringe access and collaborative practice reform to increase access to naloxone as well as pre- and post-exposure prophylaxis of HIV. Dan Scales has also spent time as a member of various nonprofit Boards of Directors, previously chaired Colorado’s Medical Assistance and Service Advisory Board, currently co-chairs Denver’s Fast Track Cities Initiative, and sits on Colorado’s State Drug Assistance Program Medical Advisory Board.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Associate Professor of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, IL
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP

Dr. Milena Murray is an Associate Professor of Pharmacy Practice at the Midwestern University College of Pharmacy, Downers Grove campus and a System-Level HIV/ID Clinical Pharmacist at Northwestern Medicine. She completed her Doctor of Pharmacy degree at the Philadelphia College of Pharmacy and her Masters of Science in Clinical Investigation at Northwestern University. Her post-graduate training consisted of a PGY-1 Pharmacy Residency at Maimonides Medical Center in Brooklyn, NY and an Infectious Diseases Pharmacotherapy Fellowship at Northwestern Memorial Hospital through Midwestern University. Her primary research interests are drug shortages and HIV/hepatitis C pharmacotherapy. Dr. Murray is a Board Certified Infectious Diseases Pharmacist and an AAHIVM HIV Pharmacist.

Statement of Need

HIV pre-exposure prophylaxis (PrEP) is no longer a one-size-fits-all approach. Today, multiple options and dosage forms exist to offer individualized protection for the 1.2 million people in the United States for whom PrEP is recommended. As medication experts of the health care team, pharmacists need to be able to educate patients and prescribers alike on the indications, safety, efficacy, administration, and prescribing requirements of new PrEP agents. However, surveys of learning and confidence across the United States reveal that approximately 50%-70% of practicing pharmacists lack sufficient knowledge to counsel on PrEP therapy.

In part 2 of this CMEO podcast series, New Horizons in HIV Prevention Education: A Closer Look at Novel Therapies, join Drs. Milena Murray and Dan Scales as they review recent advances in HIV prevention products and address knowledge gaps in the HIV health care continuum.

Learning Objectives

At the end of this CME/CE activity, participants should be able to evaluate the efficacy and safety data for current and emerging PrEP to optimize long-term outcomes for patients and improve the continuum of care.

Financial Support

Supported by an educational grant from Gilead Sciences, Inc. This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the developmental content or selection of faculty for this educational activity.

Target Audience


Credit Information

Pharmacists/Pharmacy Tech (ACPE) 0.5

This application-based activity is approved for 0.5 contact hours (0.05 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-22-054-H04-P

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Scales reports no financial relationships.

Dr. Murray reports the following financial relationships: Advisory Board: Janssen Pharmaceuticals, Inc.; Theratechnologies Inc; and ViiV Healthcare Speakers Bureau: Merck & Co., Inc.

The following CME Outfitters Staff have no financial relationships to disclose:

  • Kellie Busby, PharmD (planning committee)
  • Julie Strickland, PharmD (planning committee)
  • Susan Perry (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767.



New Horizons in HIV Prevention Education: A Closer Look at Novel Therapies
Event Date: 04/01/2022